I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Combination of Ipilimumab and Adoptive Cell Therapy with Tu..:
John E. Mullinax
;
MacLean Hall
;
Sangeetha Prabhakaran
...
http://journal.frontiersin.org/article/10.3389/fonc.2018.00044/full. , 2018
Link:
https://doi.org/10.3389/fonc.2018.00044
RT Journal T1
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:3e14ab4dede64fa39939188dae9bb51b&Exemplar=1&LAN=DE A1 John E. Mullinax A1 MacLean Hall A1 Sangeetha Prabhakaran A1 Jeffrey Weber A1 Nikhil Khushalani A1 Zeynep Eroglu A1 Andrew S. Brohl A1 Joseph Markowitz A1 Erica Royster A1 Allison Richards A1 Valerie Stark A1 Jonathan S. Zager A1 Linda Kelley A1 Cheryl Cox A1 Vernon K. Sondak A1 James J. Mulé A1 Shari Pilon-Thomas A1 Amod A. Sarnaik PB Frontiers Media S.A. YR 2018 K1 adoptive cell therapy K1 melanoma K1 ipilimumab K1 checkpoint inhibitor K1 immunotherapy K1 tumor-infiltrating lymphocytes K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://journal.frontiersin.org/article/10.3389/fonc.2018.00044/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2018.00044 DO https://doi.org/10.3389/fonc.2018.00044 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)